Loading organizations...
§ Private Profile · Wilmington, DE, USA
AI systems for personalized healthcare analytics in pharma & life science companies, enabling conversation-driven data exploration.
Flyway Health is a developer of artificial intelligence agents and conversation-driven data exploration systems designed for personalized healthcare assistance, operating from an undisclosed headquarters location. The enterprise focuses on modernizing complex data analysis and strategic decision-making processes within the pharmaceutical and life sciences sectors by addressing critical gaps in medical data collection. These proprietary software tools enable commercial healthcare organizations to perform advanced analytics efficiently without relying on traditional data management systems. To support its ongoing technological development and initial market penetration, the enterprise has secured $1 million in early-stage, pre-graduation investment capital. The underlying analytical framework draws upon the technical research experience of its leadership team at recognizable institutions including the Massachusetts Institute of Technology and Princeton University. Flyway Health was established in an undisclosed year by co-founders Taylan Ozdemir Aydin and Andre Biehl.
Flyway Health has raised $4.0M across 2 funding rounds.
Flyway Health has raised $4.0M in total across 2 funding rounds.
Flyway Health has raised $4.0M in total across 2 funding rounds.
Flyway Health's investors include Greg Field, Pear VC.
Flyway Health has raised $4.0M across 2 funding rounds. Most recently, it raised $3.0M Seed in November 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 24, 2025 | $3M Seed | Greg Field | Pear VC | Announced |
| Oct 17, 2025 | $1M Venture Round | — | — | Announced |